Associated Papers
Novel alpha interferon (IFN-alpha) variant with improved inhibitory activity against hepatitis C virus genotype 1 replication compared to IFN-alpha2b therapy in a subgenomic replicon system.
Escuret V et al.
Antimicrobial Agents and Chemotherapy, 2006
Select a paper to view details